Albuterol
Albuterol is an intervention with 53 clinical trials. Currently 2 active trials ongoing. Historical success rate of 95.0%.
Success Metrics
Based on 38 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
9
Mid Stage
18
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.4%
38 of 45 finished
15.6%
7 ended early
2
trials recruiting
53
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma
Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype
Treating Exacerbations of Asthma With Oral Montelukast in Children
Secondhand Smoke Respiratory Health Study
Clinical Trials (53)
A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma
Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype
Treating Exacerbations of Asthma With Oral Montelukast in Children
Secondhand Smoke Respiratory Health Study
Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)
Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic Fibrosis
Mechanisms for Dyspnea on Exertion in Children With Obesity and Asthma: Distinct Physiological Phenotypes
A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma
Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics
Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.
Albuterol HFA MDI in Pediatric Participants With Asthma
Effect of Inhaled Albuterol in Pulmonary Hypertension
Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma
Comparison of Nebulizers in ED in Pediatric Asthma Patients
Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults
Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease
Effects of Noninvasive Ventilation Compared to Salbutamol
Safety and Efficacy of Albuterol in Individuals With Late-onset Pompe Disease
Albuterol in Individuals With Late Onset Pompe Disease (LOPD)
Drug Details
- Intervention Type
- COMBINATION PRODUCT
- Total Trials
- 53